Task: Answer the MCQ question.
Question: Which drug exhibits a -66.139% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCCn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccco1
(b) CC(NCCCOc1cccc2ccccc12)c1ccccc1.O=C(O)C(=O)O
Answer: a. CCCn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccco1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccco1
CCCn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccco1
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[5-(furan-2-yl)-4-propyl-1,2,4-triazol-3-yl]sulfanyl]acetamide